High-risk SurgeryHeCoMoNCT06355362
Association of Intraoperative Hemodynamic Characteristics to Postoperative Complications and Mortality
An observational study of High-risk Surgery, run by Kliniken Essen-Mitte.
Trial summary
Worldwide, about 400 million major surgeries are performed annually. The scarce data available in the literature still suggest high postoperative morbidity and mortality, even in Europe. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- High-risk Surgery
- How many people
- 1,000 participants
- Where
- No sites listed yet
- Study dates
- 1 Sep 2024to 30 Jun 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The decision as to whether a surgical procedure has an increased risk of postoperative complications and/or postoperative mortality is the responsibility of the study leader at the respective study site. The list of surgical procedures will be agreed between the study site and the head of the study. The presence or absence of co-morbidities is not included in the assessment of perioperative risk.
Who may be able to join
- Patients undergoing elective surgery with increased postoperative morbidity and/or increased postoperative mortality
Who cannot join
- Patients undergoing surgery in the field of obstetrics
- Age < 18 years
- Lack of written informed consent
- Lack of language understanding
- Unwillingness to store disease data on site and share anonymised data as part of the clinical trial
Trial locations and contacts
No sites are listed yet.
About this study
Worldwide, about 400 million major surgeries are performed annually. The scarce data available in the literature still suggest high postoperative morbidity and mortality, even in Europe. Data of the World Health Organization on causes of death suggest that death after surgery would be the number three cause of mortality if it were considered a separate cause of death. However, there is little structured or high-quality data on postoperative mortality in the literature.
The aim of this study project is to collect data on postoperative complications and mortalities worldwide and to establish a Perioperative Outcome Study Platform on this topic.
Read more
In the first study of this platform, we aim to investigate the association of hemodynamic characteristics with postoperative complications and mortality. It is a prospective, multi-center study.
In addition, the investigators aim to collect data on the structural characteristics of the study sites and, for each patient, characteristics of quality of perioperative care in order to analyze associations with hemodynamic characteristics and postoperative complications and mortalities.
Read the detailed description
Preamble
The Perioperative Outcome (POP-OUT) project aims to improve care for our patients and intends to build a community of physicians from all over the world being dedicated to that aim.
The purpose and vision of the Perioperative Outcome study project
In perioperative care outcome data about postoperative mortality and morbidity is rare. This project aims to fill that gap with a prospective international database collecting perioperative data of surgical patients and relate them to postoperative mortality and morbidity.
The project is planned as initial observational study to build up the structures and define the case. Subsequently, based on that initial project the investigators further develop the study platform. This platform should adapt, grow, and broaden according to the results and possibilities seen in the study generations year by year. The intention is not to set-up a study group that finishes its work if the study is performed, but they hand on the study to the next generation of the community.
The vision is that in the future the outcome data offer the possibility to diversify, plan and power statistically prospective intervention trials to address the mortality and morbidity of our patients.
The idea is to establish a global community of anesthetists and intensivists to develop such a study platform together. The community is stronger than everything else.
The first steps of the study platform
The goal is to start with an initial observational trial about hemodynamic perioperative characteristics (fluids, vasopressors, inotropes, transfusions, hypotensive events) and short- and long-term outcomes.
The outcome measures should be in the short-term postoperative complications according to the classification of CLAVIEN-DINDO greater or equal to IIIb (example lists will be provided to the community, but the main point is that greater or equal to the category IIIB requires an intervention making it transparent in the documentation process).
The long-term outcome will be mortality (in-hospital, three-months, or one-year mortality).
The working title should be: "Association of Hemodynamic characteristics to postoperative Complications and Mortality" with the short title: "HeCoMo".
But it is like a pilot trial offering us the possibility to build up a platform structure to continuously develop perioperative outcome studies in all fields of perioperative care.
Which patients to include in the first observational trial
The initial main study population will be high-risk surgery, but this is not limited nor fixed for now nor for future projects.
It will be up to the community which specialties we will include or if we stratify the surgical populations, but the actual plan is to define a positive list of surgeries to be included. As example we can list for abdominal procedures:
- esophageal resection
- gastric resection with intestinal anastomosis
- pancreatic resections (whole organ, head, or tail)
- multivisceral procedures, e.g., cancer debulking due to ovarian cancer
- urological cystectomies.
Study aims of the initial observational trial
The primary hypothesis of the first observational trial is to test which hemodynamic measures are associated to postoperative morbidity or mortality. The measures to test are the cumulative amount and the longitudinal aspects of the intraoperative values of:
- intravenous infusion volume
- fluid balance
- hypotensive events
- vasopressor administration
- administration of inotropes
- any type of transfusions
It must be stated that the innovation of the study is not the study design nor its fancy primary outcome measures or statistical analysis. The issue is that it is a question not explicitly addressed in the literature and international short- and long-term outcome are not available in this context.
The idea is that every center includes 15-25 patients in the sequence of their appearance.
But nevertheless, the study goal is of clinical relevance and will offer the opportunity to be published at a good scientific level.
Data management
An important feature is that the data should belong to the community. That means that after the initial primary publication of every study generation the data can be used for subsequent sub-analysis or to plan subsequent powered intervention studies. At the end the long-term goal of that project is that the data are owned by the community.
The development of the electronic case report form is planned. The data acquisition will be in RedCap hosted on the server and the management of the Evangelische Kliniken Essen-Mitte, Essen, Germany by the Department of Anesthesiology, Intensive Care Medicine, and Pain therapy.
The data can be entered in the system via a webpage or via smartphone or tablet online and offline.
Ethical consent and vote by the competent authority
Obtaining an ethical vote by the competent authority and depending on the vote perceiving informed consent is up to the local institutions. In some countries it may be possible to conceive a waiver of individual patient consent. But this must be cleared out at the national level by the national coordinators. An important argument for the waiver is that the study population is more representative and is not biased by selection bias. Additionally, the study participation is expected at no additional risk for the study patients.
The general idea is that this project is a prospective, indefinite database related to perioperative outcome with sub-questions regarding hemodynamic, respiratory, metabolic, etc. issues.
Funding of the project
It is important to state that this project will have no funding by a medical society or any other entity. To be independently the study should be based by the voluntary activities of their contributors or by the departmental funding of any involved institution. However, during the development of the study platform it can be required to receive funding for maintaining data management structures or similar requirements. If the steering committee agrees on such a particular funding approach the community will be informed.
The structure of the study group
The idea is to define a steering committee and national coordinators. They are granted co-authorship for the resulting publication. But everybody taking responsibility and care of the project will be mentioned in the acknowledgements.
An exact statement about authorship of any analysis of the project will be send to everybody involved in the study platform prior to the inclusion of the first study patient.
The national coordinators take responsibility of the organization and recruitment of the study centers within his/her own country or region.
- Conditions
- High-risk Surgery
- Keywords
- hemodynamic, transfusion, perioperative process quality, intensive care medicine, complications, mortality
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of postoperative complications
The postoperative complications are graded according to the CLAVIEN-DINDO classification
Measured: From the time of surgery up to hospital discharge or up to the 30th postoperative day
Incidence of postoperative mortalities
The incidence of postoperative mortality during the follow-up period
Measured: From the time of surgery up to one year after surgery, during hospital stay, at three, six, or twelve months after surgery
Secondary outcomes (10)
Implementation rate of preoperative factors impacting postoperative outcome
Implementation rate in percentage of preoperative factors like fasting periods, preoperative carbohydrate drinks or the use of bowel preparations
Measured: During the 48 hours prior to surgery
Intraoperative hemodynamic characteristics
The longitudinal course and punctual values during surgery of haemodynamic parameters like heart rate and mean arterial pressures and therapies such as infusion volumes and balances, and catecholamine administration
Measured: Time period during surgery
Postoperative haemodynamic characteristics
The longitudinal course and punctual values after surgery up to the third postoperative day of haemodynamic parameters like heart rate and mean arterial pressures and therapies such as infusion volumes and balances, and catecholamine administration
Measured: Time period from the end of surgery up to the third postoperative day
Co-morbidities of patients
Descriptive data about the co-morbidities of the study patients
Measured: At the day of surgery
Transfusion of blood components and administration of coagulation factors
The number of transfusions of packed red blood cells, plasma, or thrombocytes as well as coagulation factors per patients
Measured: During hospital stay or up to the 30th postoperative day
Score of the physical/pathological activity status of the patients
Score of the the exercise ability in metabolic equivalent of task units
Measured: During the 48 hours prior to surgery
Clinical frailty scale
Score according to the clinical frailty scale in categories 1 to 9
Measured: During the 48 hours prior to surgery
Characteristics of perioperative care, time in perioperative units and the hospital
Length of patient stay in the hospital, time pre- and postoperatively in hospital, stay in recovery room, post-anesthesia care unit, intensive care medicine.
Measured: During hospital stay or up to the 30th postoperative day
Characteristics of provision of anesthesia and type of pain therapy
Data about the type of anaesthesia and the drugs used with their doses as well as the drugs and methods and drugs to control pain
Measured: Time period from the start of anaesthesia up to the third postoperative day
Implementation rate of items perioperatively impacting outcome within an Enhanced-Recovery-After-Surgery pathway description
The implementation rate in percentage of perioperative items related to perioperative treatment modalities
Measured: During hospital stay or up to the 30th postoperative day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Apr 2024
- Study start1 Sep 2024 (estimated)
- Primary completion30 Jun 2025 (estimated)
- Study completion30 Jun 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for High-risk SurgeryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kliniken Essen-Mitte
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Aarne Feldheiser, Principal investigator, Kliniken Essen-Mitte
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06355362
- Sponsor's protocol ID
- HeCoMo
- Acronym
- HeCoMo
- Status last verified
- Jul 2024
- First submitted
- 19 Mar 2024
- Last updated
- 26 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 26 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Association of Intraoperative Hemodynamic Characteristics to Postoperative Complications and Mortality
- ClinicalTrials.gov ID
- NCT06355362
- Acronym / sponsor ID
- HeCoMo / HeCoMo
- Conditions
- High-risk Surgery
- Keywords
- hemodynamic, transfusion, perioperative process quality, intensive care medicine, complications, mortality
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- Kliniken Essen-MitteUniversity, hospital or other
- Study start
- 1 Sep 2024 (estimated)
- Primary completion
- 30 Jun 2025 (estimated)
- Study completion
- 30 Jun 2025 (estimated)
- First posted
- 9 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Worldwide, about 400 million major surgeries are performed annually. The scarce data available in the literature still suggest high postoperative morbidity and mortality, even in Europe. Data of the World Health Organization on causes of death suggest that death after surgery would be the number three cause of mortality if it were considered a separate cause of death. However, there is little structured or high-quality data on postoperative mortality in the literature.
The aim of this study project is to collect data on postoperative complications and mortalities worldwide and to establish a Perioperative Outcome Study Platform on this topic.
In the first study of this platform, we aim to investigate the association of hemodynamic characteristics with postoperative complications and mortality. It is a prospective, multi-center study.
In addition, the investigators aim to collect data on the structural characteristics of the study sites and, for each patient, characteristics of quality of perioperative care in order to analyze associations with hemodynamic characteristics and postoperative complications and mortalities.
Detailed description
Preamble
The Perioperative Outcome (POP-OUT) project aims to improve care for our patients and intends to build a community of physicians from all over the world being dedicated to that aim.
The purpose and vision of the Perioperative Outcome study project
In perioperative care outcome data about postoperative mortality and morbidity is rare. This project aims to fill that gap with a prospective international database collecting perioperative data of surgical patients and relate them to postoperative mortality and morbidity.
The project is planned as initial observational study to build up the structures and define the case. Subsequently, based on that initial project the investigators further develop the study platform. This platform should adapt, grow, and broaden according to the results and possibilities seen in the study generations year by year. The intention is not to set-up a study group that finishes its work if the study is performed, but they hand on the study to the next generation of the community.
The vision is that in the future the outcome data offer the possibility to diversify, plan and power statistically prospective intervention trials to address the mortality and morbidity of our patients.
The idea is to establish a global community of anesthetists and intensivists to develop such a study platform together. The community is stronger than everything else.
The first steps of the study platform
The goal is to start with an initial observational trial about hemodynamic perioperative characteristics (fluids, vasopressors, inotropes, transfusions, hypotensive events) and short- and long-term outcomes.
The outcome measures should be in the short-term postoperative complications according to the classification of CLAVIEN-DINDO greater or equal to IIIb (example lists will be provided to the community, but the main point is that greater or equal to the category IIIB requires an intervention making it transparent in the documentation process).
The long-term outcome will be mortality (in-hospital, three-months, or one-year mortality).
The working title should be: "Association of Hemodynamic characteristics to postoperative Complications and Mortality" with the short title: "HeCoMo".
But it is like a pilot trial offering us the possibility to build up a platform structure to continuously develop perioperative outcome studies in all fields of perioperative care.
Which patients to include in the first observational trial
The initial main study population will be high-risk surgery, but this is not limited nor fixed for now nor for future projects.
It will be up to the community which specialties we will include or if we stratify the surgical populations, but the actual plan is to define a positive list of surgeries to be included. As example we can list for abdominal procedures:
- esophageal resection
- gastric resection with intestinal anastomosis
- pancreatic resections (whole organ, head, or tail)
- multivisceral procedures, e.g., cancer debulking due to ovarian cancer
- urological cystectomies.
Study aims of the initial observational trial
The primary hypothesis of the first observational trial is to test which hemodynamic measures are associated to postoperative morbidity or mortality. The measures to test are the cumulative amount and the longitudinal aspects of the intraoperative values of:
- intravenous infusion volume
- fluid balance
- hypotensive events
- vasopressor administration
- administration of inotropes
- any type of transfusions
It must be stated that the innovation of the study is not the study design nor its fancy primary outcome measures or statistical analysis. The issue is that it is a question not explicitly addressed in the literature and international short- and long-term outcome are not available in this context.
The idea is that every center includes 15-25 patients in the sequence of their appearance.
But nevertheless, the study goal is of clinical relevance and will offer the opportunity to be published at a good scientific level.
Data management
An important feature is that the data should belong to the community. That means that after the initial primary publication of every study generation the data can be used for subsequent sub-analysis or to plan subsequent powered intervention studies. At the end the long-term goal of that project is that the data are owned by the community.
The development of the electronic case report form is planned. The data acquisition will be in RedCap hosted on the server and the management of the Evangelische Kliniken Essen-Mitte, Essen, Germany by the Department of Anesthesiology, Intensive Care Medicine, and Pain therapy.
The data can be entered in the system via a webpage or via smartphone or tablet online and offline.
Ethical consent and vote by the competent authority
Obtaining an ethical vote by the competent authority and depending on the vote perceiving informed consent is up to the local institutions. In some countries it may be possible to conceive a waiver of individual patient consent. But this must be cleared out at the national level by the national coordinators. An important argument for the waiver is that the study population is more representative and is not biased by selection bias. Additionally, the study participation is expected at no additional risk for the study patients.
The general idea is that this project is a prospective, indefinite database related to perioperative outcome with sub-questions regarding hemodynamic, respiratory, metabolic, etc. issues.
Funding of the project
It is important to state that this project will have no funding by a medical society or any other entity. To be independently the study should be based by the voluntary activities of their contributors or by the departmental funding of any involved institution. However, during the development of the study platform it can be required to receive funding for maintaining data management structures or similar requirements. If the steering committee agrees on such a particular funding approach the community will be informed.
The structure of the study group
The idea is to define a steering committee and national coordinators. They are granted co-authorship for the resulting publication. But everybody taking responsibility and care of the project will be mentioned in the acknowledgements.
An exact statement about authorship of any analysis of the project will be send to everybody involved in the study platform prior to the inclusion of the first study patient.
The national coordinators take responsibility of the organization and recruitment of the study centers within his/her own country or region.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The decision as to whether a surgical procedure has an increased risk of postoperative complications and/or postoperative mortality is the responsibility of the study leader at the respective study site. The list of surgical procedures will be agreed between the study site and the head of the study. The presence or absence of co-morbidities is not included in the assessment of perioperative risk.
Key inclusion criteria (1 listed)
- Patients undergoing elective surgery with increased postoperative morbidity and/or increased postoperative mortality
Key exclusion criteria (5 listed)
- Patients undergoing surgery in the field of obstetrics
- Age < 18 years
- Lack of written informed consent
- Lack of language understanding
- Unwillingness to store disease data on site and share anonymised data as part of the clinical trial
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Incidence of postoperative complications
Time frame: From the time of surgery up to hospital discharge or up to the 30th postoperative day
The postoperative complications are graded according to the CLAVIEN-DINDO classification
Incidence of postoperative mortalities
Time frame: From the time of surgery up to one year after surgery, during hospital stay, at three, six, or twelve months after surgery
The incidence of postoperative mortality during the follow-up period
10 secondary outcomes
Implementation rate of preoperative factors impacting postoperative outcome
Time frame: During the 48 hours prior to surgery
Intraoperative hemodynamic characteristics
Time frame: Time period during surgery
Postoperative haemodynamic characteristics
Time frame: Time period from the end of surgery up to the third postoperative day
Co-morbidities of patients
Time frame: At the day of surgery
Transfusion of blood components and administration of coagulation factors
Time frame: During hospital stay or up to the 30th postoperative day
Score of the physical/pathological activity status of the patients
Time frame: During the 48 hours prior to surgery
Clinical frailty scale
Time frame: During the 48 hours prior to surgery
Characteristics of perioperative care, time in perioperative units and the hospital
Time frame: During hospital stay or up to the 30th postoperative day
Characteristics of provision of anesthesia and type of pain therapy
Time frame: Time period from the start of anaesthesia up to the third postoperative day
Implementation rate of items perioperatively impacting outcome within an Enhanced-Recovery-After-Surgery pathway description
Time frame: During hospital stay or up to the 30th postoperative day
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jul 2024.
- Webpage of the study platformLink provided by the sponsor.
- Individual participant dataSharing planned: Undecided
Related trials for High-risk Surgery
RecruitingPhase 2
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Breast Neoplasms, Breast Cancer
Not yet recruitingPhase 2
Pucotenlimab, Lenvatinib, and SBRT Before Surgery for Localized Clear Cell Renal Cell Carcinoma
Localized Clear Cell Renal Cell Carcinoma
RecruitingPhase 2
A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.
High-risk Localized Prostate Cancer
Not yet recruiting
High-Flow Nasal Oxygen-Assisted Deep Extubation Versus Awake Extubation in Morbidly Obese Patients
Deep Tracheal Extubation
RecruitingPhase 2/3
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Aarne Feldheiser principal investigator
Kliniken Essen-Mitte
Questions about this trial
What is this clinical trial studying?
An observational study of High-risk Surgery, run by Kliniken Essen-Mitte.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 26 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Aarne Feldheiser, MD, PhD (+4920117431001, a.feldheiser@kem-med.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of postoperative complications (time frame: From the time of surgery up to hospital discharge or up to the 30th postoperative day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jul 2024.